Status: Not yet recruiting
A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years
The goal of this clinical trial is to learn whether DEP114 is effective in treating acute exacerbations of persistent allergic rhinitis in children aged 6 to less than 12 years. The study will also evaluate the safety of DEP114. Participants will: * Take DEP114 or desloratadine once daily for 5 days (up to a maximum of 7 days). * Keep a diary of their symptoms.
Participants needed: 316
Trial details
Phase: Phase 3Age: 6-12Biological sex: AllType: InterventionalSponsor: EMSUpdated: Sep 22, 2026
Eligibility criteria
Ability to confirm voluntary participation and agreement with all study objectiv... [+5]
Use of prednisolone or any other oral or parenteral corticosteroid within 7 days... [+18]